Skip main navigation

Role of Patient Advocacy Organizations in drug repurposing and a successful repurposing case

The synergy between patients, researchers and industry is fundamental to boost drug repurposing. Watch Rick Thompson explain why and how.

The role of people living with a rare disease is fundamental in promoting preclinical and clinical research for rare diseases and this is also true for drug repurposing. Rick Thompson will now explain why and how, also by illustrating the successful case of Nitisione, a drug used for the treatment of Alkaptonuria.

This article is from the free online

From Lab to Clinic: Translational Research for Rare Diseases

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now